Merix Bioscience, Inc.

Durham, NC, US· latest recorded location

Merix Bioscience, Inc. is named on 1 US grants and 0 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).

Granted patents: 1
Published applications: 0
Inventors: 3
Granted in 2026 so far: 0
Most recent grant: 5 Nov 2002

Filings by year

Merix Bioscience, Inc.: granted patents and published applications per publication year
Year	Granted patents	Published applications
2002	1	0

By publication year.

Technology areas

Share of 1 documents

A61KMedicines and medical preparations1
A61PTherapeutic uses of medicines1
C12NMicroorganisms or enzymes1

Recent patents

Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases5 Nov 2002US 6,475,483 B1

All 1 patents

Most cited

By later US patents

Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens for treating autoimmune diseases11US 6,475,483 B12002